News
Identified a brain circuit that could indicate the risk of developing Alzheimer’s in healthy people
Researchers from IDIBELL and CIBERSAM have discovered how alterations in the connectivity of two regions of the brain represents a potential biomarker for Alzheimer’s vulnerability.
IDIBELL and Dexeus Mujer will study embryonic development through human embryo genome edition
The team of Dra. Anna Veiga, who leads the study, will optimize the CRISPR/Cas9 technique to modify the human embryo genome
IDIBELL researchers discover that a molecule of blood is effective against autoimmune kidney disease
The administration of C4BP (beta-) in mice that reproduce lupus nephritis considerably improves the symptomatology of the disease.
The agreement of the audiovisual project ‘What and how to eat during cancer’ was presented
When a cancer is diagnosed, a host of questions spring to the patient’s: about medical treatment, new day-to-day, his new life … Also about a new way of feeding. An adequate diet is essential to guarantee the good nutritional status in order to tolerate these cancer treatments. In short, it is key to cope with the disease.
Identified a determinant protein for tumor progression and metastasis in childhood cancer Rhabdomyosarcoma
LOXL2 protein levels are increased in the cells from this type of sarcoma.
Inhibition of p38 reduces the growth of lung tumors
The work shows that patients with low levels of this protein have a better prognosis.
IDIBELL researchers Antonella Consiglio and Ángel Raya, awarded with the City of Barcelona Award
Two researchers from the Bellvitge Biomedical Research Institute (IDIBELL), have been awarded in this edition of the City of Barcelona Awards, in the Life Sciences category. Dr. Antonella Consiglio, principal investigator of the group of stem cells and neurodegenerative diseases of IDIBELL, ICREA academy researcher, and professor at the Faculty of Medicine and Health Sciences […]
On World Cancer Day we will celebrate HealthTech World Day
In World Cancer Day, NanoMed organizes the seventh edition of the HealthTech World Cancer Day. An event in which the latest innovations in nanomedicine cancer filed, will be announced. Experts will talk about issues ranging from early diagnosis, controlled drug release or radiotherapy with nanoparticles. The Bioengineering Institute of Catalonia (IBEC) and the Bellvitge Biomedical […]
Dimethyl fumarate obtained orphan drug designation for the treatment of adrenoleukodystrophy
The European Medicines Agency (EMA) has approved dimethyl fumarate (DMF) as an orphan drug for the treatment of adrenoleukodystrophy, a rare fatal neurometabolic disorder. Dimethyl fumarate is an activator of the NFR2 pathway, which enhances cellular defense and protection against oxidative damage. Dimethyl fumarate can reduce the inflammatory response and promote the protection of central […]